Third New Treatment for Multiple Myeloma Approved in November
On Monday, the U.S. Food and Drug Administration (FDA) rounded out an exciting month for the multiple myeloma community...
Category: Research
On Monday, the U.S. Food and Drug Administration (FDA) rounded out an exciting month for the multiple myeloma community...
As lung cancer awareness month drew to a close, the U.S. Food and Drug Administration (FDA) added another therapeutic...
On Monday, the U.S. Food and Drug Administration (FDA) announced that it had approved the use of the immunotherapeutic...
The flurry of decisions from the U.S. Food and Drug Administration (FDA) on investigational anticancer therapeutics continued last week...
Last week, the U.S. Food and Drug Administration (FDA) provided some good news for the lung cancer community during...
Last week, the U.S. Food and Drug Administration (FDA) approved the use of cobimetinib (Cotellic) in combination with vemurafenib...
The flurry of anticancer therapeutics approved by the U.S. Food and Drug Administration (FDA) late last month included the...
Earlier this week, the U.S. Food and Drug Administration (FDA) approved a first-of-its kind immunotherapeutic, talimogene laherparepvec or T-Vec...
Yesterday, Onivyde, which is a nanotherapeutic form of the conventional chemotherapeutic irinotecan, was approved by the U.S. Food and...
Guest Post by Roswell Park Cancer Institute Department of Public Affairs